drugset / Trial / NCT05841056

Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial

NCT05841056

Phase 3 Recruiting 400 enrolled Population Health Research Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

The START-POAF pilot study is a prospective, open-label two-arm, randomized controlled trial with blinded assessment of outcomes (PROBE). This pilot study will assess Atrial Fibrillation (AF) recurrence and burden in patients with new-onset AF following cardiac surgery.

Timeline

Start
2024-06-13
Primary completion
2028-08-31
Completion
2028-11-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amiodarone Small molecule 200 mg

Indications